- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03987607
Comparison of Two Monitors That Measure Neuromuscular Function During Surgeries
Comparison of Electromyography-based TetraGraph and Acceleromyography-based TOF-Watch SX Neuromuscular Monitors Under Clinical Conditions
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this single center, one-arm, observational, prospective, non-inferiority study is to compare neuromuscular data obtained with two neuromuscular monitors. The two monitors are the electromyography-based TetraGraph neuromuscular monitor and the acceleromyography-based TOF-WATCH SX device.
The study will enroll 50 patients undergoing elective surgeries that require muscle relaxation. Patients will be only enrolled after written informed consent is obtained. Exclusion criteria include: neuromuscular disease in patient history, patient taking any medication that affects neuromuscular transmission, open wound or sores at the site of electrode placement, expected difficult airway, pregnancy or breastfeeding state, or implanted pacemaker.
The study will be conducted using one of the patient's arms. Both neuromuscular monitors will be applied on the same arm. The monitors will be connected by optical cable link to synchronize nerve stimulation and data recording. The aim of this setting is to obtain both acceleromyography and electromyography signals of the adductor pollicis muscle in response to ulnar nerve stimulation. This setting ensures identical stimulation conditions for the two monitors. Only the TOF-Watch SX will be used for nerve stimulation while the TOF-Watch will collect acceleromyography data of the thumb and TetraGraph will collect the electromyography data of the adductor pollicis muscle.
The ulnar nerve will be stimulated via single use electrocardiography electrodes used by TOF-Watch SX. The piezoelectric probe of TOF-Watch SX will be applied on the thumb via hand adapter, according to the manufacturer's instructions. The stimulating electrodes of TetraGraph will be isolated, since the device will not deliver electrical stimulation, only register the compound muscle action potentials of the adductor pollicis muscle evoked by TOF-Watch SX stimulation. The sensing electrodes of TetraGraph will be applied above the thenar and the interphalangeal joint of the thumb.
The TetraGraph monitor used for the study has a modified software compared to the commercially available monitors. This study device is used only for the current study.
Also, the cable of the TOF-Watch SX monitor has been modified to connect to the TetraGraph monitor for synchronization . The results of the responses analyzed by the TetraGraph device will not be used for clinical care decisions.
Neuromuscular monitoring will be started after the induction of anesthesia before the administration of neuromuscular blocking agent and terminated at the extubation of the patient. After calibration, the TOF-Watch will be left to stimulate automatically every 15 sec. Neuromuscular monitoring will be performed during surgery according to clinical standards, it will be stopped before extubation to avoid patient discomfort associated with neurostimulation.
During deep neuromuscular block the examiner will deliver post tetanic count stimulation every 5 min.
TOF-Watch SX data will be stored on a laptop computer using the devices software. TetraGraph is using a built-in SD card for data collection.
Beside acceleromyography and electromyography train-of-four ratios, train-of-four counts and post tetanic counts the following data will be recorded in a clinical research form:
- date of surgery, type of surgery,
- patient identification number, patient's sex, weight, height, BMI, dominant hand side,
- time of anesthesia induction, drugs used to induce anesthesia
- time of starting neuromuscular monitoring
- time of muscle relaxant administration, type and dose of muscle relaxant
- time of tracheal intubation and extubation,
- time of beginning and end of surgery
- time of reversal agent administration, type and dose of reversal agent
- use of surgical devices
To avoid uncertainty, only the data of TOF-Watch SX will be provided to the anesthesiology team for clinical use. TetraGraph data will be kept blinded from healthcare providers. All clinical decisions will be made according to TOF-Watch SX measurements, as per current clinical care. If any doubt arises regarding the reliability of the data delivered by TOF-Watch SX, the anesthesia workstations' built-in NMT modules (Infinity Trident NMT Smartpod, Draeger, Lübeck, Germany) will be used to guide clinical care.
Propofol target control infusion with bispectral index monitoring will be used to provide anesthesia. The administration of muscle relaxants, reversal agents and time of intubation and extubation will be at the discretion of the attending anesthesiologist as per usual clinical routine.
All patients will be monitored postoperatively for one day to detect any unexpected adverse events.
Statistical analysis:
Data will be analyzed offline after the completion of the study. Based on a priori sample size calculation, 50 patients will be enrolled in the study. Paired T-test and Bland-Altman analysis will be performed to examine the agreement between the two devices.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Debrecen, Hungary, 4032
- University of Debrecen, Department of anesthesiology and Intensive Care
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- elective surgery requiring neuromuscular blockade
- written informed consent
- American Society of Anesthesiology physical status I-III
Exclusion Criteria:
- neuromuscular disease in patient history,
- patient taking any medication that affects neuromuscular transmission,
- open wound or sores at the site of electrode placement,
- expected difficult airway,
- pregnancy or breastfeeding state,
- implanted pacemaker
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients scheduled for elective surgery
Patients scheduled for elective surgery requiring neuromuscular blockade
|
Neuromuscular blockade monitoring via two different types of monitoring devices
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.8-1.0
Time Frame: Prior to extubation
|
Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.8-1.0
|
Prior to extubation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.6-0.79
Time Frame: During surgery
|
o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.6-0.79
|
During surgery
|
o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.4-0.59
Time Frame: During surgery
|
o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.4-0.59
|
During surgery
|
o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.2-0.39
Time Frame: During surgery
|
o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.2-0.39
|
During surgery
|
o Agreement between acceleromyography and electromyography derived TOF counts
Time Frame: During surgery
|
o Agreement between acceleromyography and electromyography derived TOF counts
|
During surgery
|
o Agreement between acceleromyography and electromyography derived PTC counts
Time Frame: During surgery
|
o Agreement between acceleromyography and electromyography derived PTC counts
|
During surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Liang SS, Stewart PA, Phillips S. An ipsilateral comparison of acceleromyography and electromyography during recovery from nondepolarizing neuromuscular block under general anesthesia in humans. Anesth Analg. 2013 Aug;117(2):373-9. doi: 10.1213/ANE.0b013e3182937fc4. Epub 2013 Jul 2. Erratum In: Anesth Analg. 2017 May;124(5):1745.
- Naguib M, Brull SJ, Johnson KB. Conceptual and technical insights into the basis of neuromuscular monitoring. Anaesthesia. 2017 Jan;72 Suppl 1:16-37. doi: 10.1111/anae.13738.
- Kopman AF, Chin W, Cyriac J. Acceleromyography vs. electromyography: an ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation. Acta Anaesthesiol Scand. 2005 Mar;49(3):316-22. doi: 10.1111/j.1399-6576.2005.00643.x.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AITT2017/3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuromuscular Blockade
-
Hospital Federal de BonsucessoUnknownNeuromuscular Blockade | Magnesium Sulfate | Rocuronium | Deep Neuromuscular BlockadeBrazil
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedNeuromuscular Blockade | Neuromuscular MonitoringItaly
-
Universitair Ziekenhuis BrusselUnknownNeuromuscular Blockade | Neuromuscular MonitoringBelgium
-
Central Hospital, Nancy, FranceNot yet recruitingComparison of the TOFscan and the TetraGraph During Recovery of Neuromuscular Function (DECURAR-EMG)Neuromuscular BlockadeFrance
-
Vanderbilt University Medical CenterUniversity of Pittsburgh; The Cooper Health SystemRecruitingNeuromuscular BlockadeUnited States
-
Leiden University Medical CenterMerck Sharp & Dohme LLCCompletedNeuromuscular BlockadeNetherlands
-
Seoul National University Bundang HospitalCompleted
-
Poitiers University HospitalEnrolling by invitationNeuromuscular BlockadeFrance
-
Centre Hospitalier Universitaire Dinant Godinne...CompletedNeuromuscular BlockadeBelgium
-
Seoul National University HospitalCompletedNeuromuscular BlockadeKorea, Republic of
Clinical Trials on neuromuscular blockade monitoring
-
Poitiers University HospitalCompletedObservation of Neuromuscular Block | Flexor Hallucis | Adductor PollicisFrance
-
Nationwide Children's HospitalTerminatedNeuromuscular BlockadeUnited States
-
Kyung Hee University Hospital at GangdongMerck Sharp & Dohme LLCCompletedThoracic Surgery | One-lung VentilationKorea, Republic of
-
Radboud University Medical CenterMerck Sharp & Dohme LLCUnknown
-
Brno University HospitalRecruitingMuscle RelaxationCzechia
-
Università Vita-Salute San RaffaeleRecruitingNeuromuscular Blockade | Hepatic Cancer | Intraoperative BleedingItaly
-
Seoul National University Bundang HospitalUnknown
-
Konkuk University Medical CenterCompletedHip FracturesKorea, Republic of
-
Leiden University Medical CenterMerck Sharp & Dohme LLCCompletedNeuromuscular BlockadeNetherlands
-
NorthShore University HealthSystemCompletedResidual Neuromuscular Blockade in Elderly PatientsUnited States